Jeffrey A Cadeddu MD
Professor, Departments of Urology and Radiology, University of Texas Southwestern Medical Center, Dallas, Texas
Dr. Jeffrey Cadeddu received his Bachelor of Science in Biomedical Engineering from Johns Hopkins University, and in 1993 received his Doctor of Medicine from Johns Hopkins University School of Medicine, where he also completed his urology and surgery residencies. He then joined The University of Texas Southwestern Medical Center in 1999, and currently holds the dual appointments of Professor of Urology and Professor of Radiology at that institution. In addition, he holds the Ralph C. Smith, M.D. Distinguished Chair in Minimally Invasive Urologic Surgery and serves as the Director of the Clinical Center for Minimally Invasive Urologic Cancer Treatment. His affiliations include membership in the American Urological Association, the Endourological Society, the Society for Urologic Oncology, Texas Urological Society, and the Engineering and Urology Society.
Dr. Cadeddu currently serves as Associate or Assistant Editor on behalf of the Journal of Endourology, World Journal of Urology, and the International Brazilian Journal of Urology, and serves as a Survey Section Editor for the Journal of Urology. His publications include over 200 peer-reviewed articles; over 75 invited articles and book chapters; numerous editorial comments, book reviews and original videos. He is the recipient of the American Urological Association’s 2007 Gold Cystoscope Award. In April 2013, he was elected to active membership in the American Association of Genitourinary Surgeons (AAGUS), and in 2014, he was elected co-president of the Engineering and Urology Society.
Recent Contributions to PracticeUpdate:
- Cost Comparison of Percutaneous Microwave Ablation vs Partial Nephrectomy for Localized Renal Masses
- Percutaneous Microwave Ablation of Renal Masses
- Comparative Analysis of Surgery, Thermal Ablation, and Active Surveillance for Renal Oncocytic Neoplasms
- Partial Nephrectomy vs Thermal Ablation for Clinical Stage T1 Renal Masses
- Complication and Readmission Rates Following Same-Day Discharge After Percutaneous Renal Tumor Ablation